Adaptimmune Therapeutics plc
ADAP • Biotechnology
Strong market move
ADAP+19.38%
vs. previous close $0.05
$0.06
▲ +0.01 (+19.38%)
Current price
EarningsLatest report: Jun 30, 2025
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$75.16M
Growth
—
Cash Flow
1/5
Trend
Volatile
Evidence
Positive revenue growth · 124.5%Healthy liquidity · 2.92High debt level · 6.26Weak profitability
Financial data as of: Jun 30, 2025, 12:00 AM UTCLast earnings update: Aug 13, 2025, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$0.06
Change19.38%
Market Cap$75.16M
52W Range0.02 - 0.86
Beta2.49
Gross Margin99.96%
Oper. Margin-38.62%
Profit Margin-39.78%
Debt/Eq6.26
Current Ratio2.92
Quick Ratio2.80
Target$2.83
Price$0.06
Change19.38%
Market Cap$75.16M
52W Range0.02 - 0.86
Beta2.49
Gross Margin99.96%
Oper. Margin-38.62%
Profit Margin-39.78%
Debt/Eq6.26
Current Ratio2.92
Quick Ratio2.80
Target$2.83
Target Upside4787.74%
Target Median$3.00
Target Range1.00 - 4.00
Volume1.68M
Avg Volume110.64M
EPS Surprise0.02
Investment DNA
How strong this company looks for long-term investors
49
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
58/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
58/100
Why this score▼
Positive revenue growth · 124.5%Healthy liquidity · 2.92High debt level · 6.26Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
No vote count available
Bullish
0
Hold
0
Bearish
0
Price Target
2026-06-06
Low
$1.00
Mean
$2.83
Median
$3.00
High
$4.00
🧾
No insider activity
No recent insider transactions available.